Equities research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 41.2 % NASDAQ SRNE opened at $0.03 on Wednesday. The firm’s fifty day moving average price is […]